Strobeck Matthew

Director · QDEL, BDSX

As of 2026-09-16, Strobeck Matthew has 10 Form 4 transactions on record across 2 companies — 5 in the trailing 12 months.

Everything this person has disclosed to the SEC on Form 4 — across every company they file for — reconstructed from the public record. A filing history, not a tip sheet.

Reconstructed holdings

Direct: $181KIndirect: $0$181Kas of 2026-09-16
  • Direct $181K
  • Indirect $0
BDSXdirect6,354 sh$181K

Reconstructed from this person's own Form 4 filings — the total each filing reported owning afterward, priced at the close on the as-of date shown. A filed position can lag the real one.

Direct and indirect holdings (e.g. through a trust or fund) are tagged separately, as filed.

Trades by company

QDEL · 6 trades
2026-05-29: Option exercise, 6,829 sh ($0)2026-05-29: Award / grant, 6,829 sh ($0)2026-02-13: Purchase, 10,000 sh ($240K)2025-05-29: Award / grant, 6,829 sh ($0)2025-05-22: Option exercise, 4,929 sh ($0)2025-05-22: Award / grant, 4,929 sh ($0)
BDSX · 4 trades
2026-01-02: Award / grant, 6,804 sh ($0)2026-01-02: Award / grant, 6,354 sh ($0)2025-05-20: Award / grant, 80,525 sh ($0)2025-05-20: Award / grant, 42,010 sh ($0)

Filing ledger

DateCompanyActionShares @ priceValueOwnership ΔOwned afterFiling
2026-02-13QDELPurchase10,000 @ $23.96$240K+56.3% of holding27,775Form 4
9 award / exercise / gift records — not counted as purchases
DateCompanyActionSharesOwned afterFiling
2026-05-29QDELOption exercise6,8290Form 4
2026-05-29QDELAward / grant6,82934,604Form 4
2026-01-02BDSXAward / grant6,8046,804Form 4
2026-01-02BDSXAward / grant6,3546,354Form 4
2025-05-29QDELAward / grant6,8296,829Form 4
2025-05-22QDELOption exercise4,9290Form 4
2025-05-22QDELAward / grant4,92917,775Form 4
2025-05-20BDSXAward / grant80,52580,525Form 4
2025-05-20BDSXAward / grant42,01042,010Form 4

Source: SEC Form 4 filings. Each row links to its original filing.

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.